NASDAQ: OACC
Oaktree Acquisition Corp III Life Sciences Stock Ownership - Who owns Oaktree Acquisition III Life Sciences?

Insider buying vs selling

Have Oaktree Acquisition Corp III Life Sciences insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when OACC insiders and whales buy or sell their stock.

OACC Shareholders

What type of owners hold Oaktree Acquisition Corp III Life Sciences stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aqr Arbitrage LLC5.39%1,324,175$14.10MInstitution
Decagon Asset Management LLP4.08%1,002,427$10.68MInstitution
Fort Baker Capital Management LP4.07%1,000,000$10.65MInstitution
Empyrean Capital Partners LP 13.66%900,000$9.59MInstitution
D E Shaw Co Inc3.50%861,625$9.18MInstitution
Boussard Gavaudan Investment Management LLP2.93%720,000$7.67MInstitution
Linden Advisors LP2.44%600,000$6.39MInstitution
Oaktree Acquisition Holdings III Ls LLC2.38%583,981$6.22MInsider
Sculptor Capital LP2.16%530,807$5.65MInstitution
Goldman Sachs Group Inc 12.15%529,535$5.64MInstitution

1 of 3

OACC vs Shell Company Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OACC72.39%2.38%
PLMK70.97%8.33%
DMAA63.88%36.12%
TRGS78.39%0.86%Net Buying
NTWO72.02%2.01%

Oaktree Acquisition III Life Sciences Stock Ownership FAQ

Who owns Oaktree Acquisition III Life Sciences?

Oaktree Acquisition III Life Sciences (NASDAQ: OACC) is owned by 72.39% institutional shareholders, 2.38% Oaktree Acquisition III Life Sciences insiders, and 25.23% retail investors. Oaktree Acquisition Holdings III Ls LLC is the largest individual Oaktree Acquisition III Life Sciences shareholder, owning 583,981.00 shares representing 2.38% of the company. Oaktree Acquisition Holdings III Ls LLC's Oaktree Acquisition III Life Sciences shares are currently valued at $6.22M.

If you're new to stock investing, here's how to buy Oaktree Acquisition III Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.